Publications - Discoveries and Innovations from Incucyte

Total number of publications
Number of publications this year
Displaying 327 results out of a total of 2729 publications.

Filter publications:

Search publications:

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
Harper, J;Adams, KJ;Bossi, G;Wright, DE;Stacey, AR;Bedke, N;Martinez-Hague, R;Blat, D;Humbert, L;Buchanan, H;Le Provost, GS;Donnellan, Z;Carreira, RJ;Paston, SJ;Weigand, LU;Canestraro, M;Sanderson, JP;Botta Gordon-Smith, S;Lowe, KL;Rygiel, KA;Powlesland, AS;Vuidepot, A;Hassan, NJ;Cameron, BJ;Jakobsen, BK;Dukes, J;
PLoS ONE, PLoS ONE,13(10):e0205491, 2018
View publication
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Ambrogio, C;Khler, J;Zhou, ZW;Wang, H;Paranal, R;Li, J;Capelletti, M;Caffarra, C;Li, S;Lv, Q;Gondi, S;Hunter, JC;Lu, J;Chiarle, R;Santamara, D;Westover, KD;Jnne, PA;
Cell, Cell, ():, 2018
View publication
Acetonic extracts of the endolichenic fungus EL002332 isolated from Endocarpon pusillum exhibits anticancer activity in human gastric cancer cells
Yang, Y;Bae, W;Nam, S;Jeong, M;Zhou, R;Park, S;Ta?, ;Hwang, Y;Park, M;Chung, I;Kim, K;Hur, J;Kim, H;
Phytomedicine, Phytomedicine, 40():106-115, 2018
View publication
ASTX660, a novel non-peptidomimetic antagonist of cIAP1/2 and XIAP, potently induces TNF-? dependent apoptosis in cancer cell lines and inhibits tumor growth
Ward, GA;Lewis, EJ;Ahn, JS;Johnson, CN;Lyons, JF;Martins, V;Munck, JM;Rich, SJ;Smyth, T;Thompson, NT;Williams, PA;Wilsher, NE;Wallis, NG;Chessari, G;
Mol. Cancer Ther., Mol. Cancer Ther., ():, 2018
View publication
PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors
Januario, T;Ye, X;Bainer, R;Alicke, B;Smith, T;Haley, B;Modrusan, Z;Gould, S;Yauch, RL;
Proc. Natl. Acad. Sci. U.S.A., Proc. Natl. Acad. Sci. U.S.A., 114(46):12249-12254, 2018
View publication
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity
McHugh, A;Fernandes, K;South, AP;Mellerio, JE;Salas-Alans, JC;Proby, CM;Leigh, IM;Saville, MK;
Oncotarget, Oncotarget, 9(29):20265-20281, 2018
View publication
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
Itkonen, HM;Gorad, SS;Duveau, DY;Martin, SES;
Oncotarget, 2016 Jan 27. doi: 10.18632/oncotarget.7039., 2016
View publication
Vemurafenib and trametinib reduce expression of CTGF and IL-8 in (V600E)BRAF melanoma cells
Hartman, ML;Rozanski, M;Osrodek, M;Zalesna, I;Czyz, M;
Lab. Invest, Lab. Invest, 97(97):217-227, 2017
View publication
Targeting Inhibitor of Apoptosis Proteins Protects from Bleomycin-Induced Lung Fibrosis
Ashley, SL;Sisson, TH;Wheaton, AK;Kim, KK;Wilke, CA;Ajayi, IO;Subbotina, N;Wang, S;Duckett, CS;Moore, BB;Horowitz, JC;
Am. J. Respir. Cell Mol. Biol, Am. J. Respir. Cell Mol. Biol, 54(4):482-92, 2016
View publication
p300 cooperates with c-Jun and PARP-1 at the p300 binding site to activate RhoB transcription in NSC126188-mediated apoptosis
Kim, Bo-Kyung et al
Biochimica et Biophysica Acta, 1839, 364-373, 2014
View publication
1 2 3 4 5 6 7 8 9 10 11 12 ...
No file selected
Stay up-to-date with what's happening at Essen BioScience

© 2020 Essen BioScience

Privacy Policy